Comments
Shilpa Medicare Ltd has received marketing authorisation from Germany, EU, for Amifampridine Tablets.
The company had earlier received approval from TGA, Australia for the manufacture, labelling, packaging and testing of medicinal Oral Mouth Dissolving Films (Wafers).
The stock rose by 1.67 per cent on the NSE, traded at ₹335.45 as of 1.01 pm.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.